Results 91 to 100 of about 2,407 (209)

AI‐Powered Personalization Across Digital Ecosystems: A Trust‐Centric Perspective on Intelligent, Ethical, and Adaptive User‐Centric Systems

Applied AI Letters, Volume 7, Issue 3, October 2026.
Hybrid and deep learning recommenders achieve high personalization accuracy, but sustainable adoption depends on trust: fairness, privacy, explainability and user control must be embedded across the entire personalization pipeline. ABSTRACT Personalization based on Artificial Intelligence (AI) has become a paradigm shift in user‐focused experiences in ...
Mohd Munazzer Ansari, Shailendra Kumar, Umair Tariq, Md Belal Bin Heyat   +3 more
wiley   +1 more source

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

Advanced NanoBiomed Research, Volume 6, Issue 10, October 2026.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi, Md Mijanur Rahman, Asma Talukder, Urooj Yousaf Virk, Jennifer C. Wilson, Nigel McMillan, Ming Q. Wei   +6 more
wiley   +1 more source

Immune cells in the pathogenesis of abdominal aortic aneurysm: Roles, regulation and targeted interventions

Clinical and Translational Discovery, Volume 6, Issue 5, October 2026.
This review provides a comprehensive overview of how macrophages, neutrophils, T cells and other immune cells infiltrate the aortic wall, undergo phenotypic shifts and interact with one another in abdominal aortic aneurysm (AAA). Background Abdominal aortic aneurysm (AAA) is a lethal degenerative vascular disease with no approved clinical drugs. Immune
Junqi Peng, Hanqing Zhang, Yun Wu, Song Chen   +3 more
wiley   +1 more source

Context‐dependent TREM2 signalling in myeloid cells: Molecular mechanisms and immunotherapeutic divergence in neurodegeneration and cancer

Clinical and Translational Medicine, Volume 16, Issue 10, October 2026.
Divergent triggering receptor expressed on myeloid cells 2 (TREM2) signalling pathways instruct myeloid cell adaptation towards neuroprotective disease‐associated microglia (DAM)/lipid‐associated macrophage (LAM) or immunosuppressive tumour‐associated macrophage (TAM) phenotypes.
Yaqing Lv, Mingpeng Shi, Yongfei Zhao, Yi Yu, Jiawei Lv, Hai Zhao   +5 more
wiley   +1 more source

Successful Pregnancy After Planned Pregnancy‐Oriented TKI Interruption and Embryo Transfer Following Ponatinib Re‐Consolidation in Chronic‐Phase Chronic Myeloid Leukemia

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Introduction Pregnancy after unsuccessful treatment‐free remission (TFR) in chronic‐phase chronic myeloid leukemia (CP‐CML) remains challenging. Case Presentation A woman lost major molecular response (MMR) after stopping a BCR::ABL1 tyrosine kinase inhibitor (TKI).
Fumisato Takagi, Takaaki Ono, Yuma Nagai, Yuki Nagai, Yusuke Yokota, Aoi Warashina, Takumi Okuwa, Motoyasu Fukuyo, Katsumi Koyauchi, Yujiro Ito, Satoshi Uchiyama, Tomonari Takemura, Yasuyuki Nagata   +12 more
wiley   +1 more source

Ferritin‐Based Nanomotors for Deep Glioblastoma Penetration and Enhanced Drug Delivery

Macromolecular Bioscience, Volume 26, Issue 10, October 2026.
We report an oxygen‐propelled nanomotor composed of human heavy‐chain ferritin nanocage (HFn) and catalytic CeO2 nanoparticles to enhance tumor penetration and therapeutic efficacy. HFn efficiently traversed the blood‐brain barrier (BBB), while oxygen generated by CeO2‐catalyzed H2O2 decomposition propelled the nanomotor deep into tumor spheroids ...
Jun Ma, Ruochen Liu, Ibrahim Chamseddine, Jingjing Qiu, Shiren Wang   +4 more
wiley   +1 more source

Immune‐Cell Dynamics in the Tumor Microenvironment: Implications for Cancer Therapy

MedComm, Volume 7, Issue 10, October 2026.
Immune‐cell dynamics in the tumor microenvironment converge on four major barriers to effective therapy: failed immune access, defective antigen visibility and priming, loss of effector maintenance, and suppressive tissue remodeling. These barriers emerge from local hypoxic, cytokine, metabolic, and stromal signals.
Pin Guo, Yizhao Xie, Rui Song, Mengdi Yang, Zhen Lin, Chao Guan, Zechen Wang, Jin Wen, Guang‐Liang Chen   +8 more
wiley   +1 more source

E-Atıklar Ve TFRS Yorum 6 Çerçevesinde E-Atıkların Muhasebeleştirilmesi

Selçuk Üniversitesi Sosyal Bilimler Meslek Yüksekokulu Dergisi, 2017
Bu çalışmanın amacı işletmelerin ekonomik faaliyetleri sonucu çevreye verdiği zararlardan bir tanesi olan elektrikli elektronik aletlerin atıklarına ilişkin atık yönetimi ve maliyetlerini ne şekilde muhasebeleştirdiğini ve buna ilişkin ulusal ve ...
Mustafa Ay, Yunus Ceran, Merve Öztürk
doaj  

Receptor‐Targeted Niosomal Nanocarriers: Advances, Challenges, and Opportunities in Natural Compound Delivery for Cancer Therapy

Nano Select, Volume 7, Issue 10, October 2026.
Surface‐modified niosomes are introduced as multifunctional nanoparticles for precision tumor treatment that combine hydrophilic and lipophilic drug encapsulation with ligand‐based targeting via antibodies, peptides, transferrin, and folic acid. This modification leads to increased tumor selectivity, facilitates cell entry, and enables enhanced ...
Narges Sahraei, Aryan M. Faraj, Faezeh Molaei, Abolfazl Barzegar   +3 more
wiley   +1 more source

TFRS ve KOBİ TFRS açısından maddi duran varlıkların muhasebeleştirilmesi

, 2015
İşletmelerin, küreselleşmenin bir sonucu olarak sınırlarının ortadan kalkmasıyla daha karmaşık bir yapıya sahip olmaları, finansal raporlamada da köklü değişimleri zorunlu kılmıştır. Bu ve benzeri sıkıntıların giderilerek, finansal tablolardan benzer ve doğru bilgilerin elde edilebilmesi gibi amaçlarla Uluslararası Muhasebe Standartları ve Uluslararası
openaire   +2 more sources